Dermata Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -1,772 | -2,340 | -3,150 | -3,226 |
EBIT | -1,772 | -2,340 | -6,400 | -3,226 |
Net Income | -1,701 | -2,304 | -3,151 | -3,173 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,690 | -1,934 | -2,913 | -3,418 |
Cash | 6,480 | 9,719 | 3,161 | 6,143 |
Basic Shares | 1,026 | 515 | 155 | 155 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -12,287 | 247 | -9,674 | -7,842 |
EBIT | -24,800 | -7,794 | -9,674 | -7,856 |
Net Income | -12,287 | -7,795 | -9,610 | -7,948 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -11,162 | -6,408 | -8,834 | -5,693 |
Cash | 3,161 | 7,438 | 6,241 | 10,798 |
Basic Shares | 153 | 19 | 69 | 52 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.66 |
2025-03-31 | -$1.25 |
2024-12-31 | -$0.92 |
2024-09-30 | -$20.40 |
